← 治験一覧に戻る
健康な日本人男性被験者におけるLY3526318の研究
基本情報
- NCT ID
- NCT05580250
- ステータス
- 取り下げ
- 試験のフェーズ
- 第1相
- 試験タイプ
- 介入
- 目標被験者数
- 0
- 治験依頼者名
- Eli Lilly and Company
概要
This is a study of LY3526318 in healthy male Japanese. The main purposes of this study are to: * Assess how safe and well tolerated LY3526318 is when given by mouth. * Measure how LY3526318 affects the kidney and the liver. The study will be conducted in three parts (Part A, Part B, Part C). Participants may only enroll in one part. After screening, the study will last from one to two weeks, depending on part.
対象疾患
Healthy
介入
LY3526318(DRUG)
Placebo(DRUG)
Iohexol(DRUG)
Simvastatin(DRUG)
Metformin(DRUG)
依頼者（Sponsor）
日本イーライリリー株式会社(INDUSTRY)
実施施設 (1)
福岡検疫所福岡空港検疫所支所診察室
Fukuoka, Japan